Birchview Capital, LP
- SEC CIK
- 0001618205
- Latest filing
- Aug 14, 2026
Holdings in Q3 2024
Holdings as of Sep 30, 2024, filed Jun 30, 2025. Long positions only; changes compare share counts with Q2 2024.
- Positions
- 61
- +1 vs. Q2 2024
- Portfolio value
- $115.5M
- +$7.30M (+6.7%) vs. Q2 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BMYBristol Myers Squibb Co | Stock | 686,182 | $35.5M | 30.7% | −2,036−0.3% | Reduced | History |
| BDSXBiodesix Inc | COM | 5,696,113 | $10.1M | 8.8% | 00.0% | Unchanged | History |
| ACADAcadia Pharmaceuticals Inc | COM | 400,400 | $6.16M | 5.3% | +150,000+59.9% | Added | History |
| ELUTElutia Inc. | CL A COM | 1,321,215 | $5.03M | 4.4% | −230,440−14.9% | Reduced | History |
| UTHRUnited Therapeutics Corp | COM | 10,000 | $3.58M | 3.1% | 00.0% | Unchanged | History |
| PRTAProthena Corp Public Ltd Co | SHS | 209,574 | $3.51M | 3.0% | +6,000+2.9% | Added | History |
| NBIXNeurocrine Biosciences Inc | Stock | 30,240 | $3.48M | 3.0% | −12,000−28.4% | Reduced | History |
| CORTCorcept Therapeutics Inc | COM | 74,000 | $3.42M | 3.0% | 00.0% | Unchanged | History |
| HROWHarrow, Inc. | COM | 72,910 | $3.28M | 2.8% | −77,090−51.4% | Reduced | History |
| QDELQuidelOrtho Corp | COM | 67,619 | $3.08M | 2.7% | 00.0% | Unchanged | History |
| FHTXFoghorn Therapeutics Inc. | COM | 320,930 | $2.99M | 2.6% | 00.0% | Unchanged | History |
| AXGNAxogen, Inc. | COM | 197,000 | $2.76M | 2.4% | 00.0% | Unchanged | History |
| PHRPhreesia, Inc. | COM | 114,700 | $2.61M | 2.3% | 00.0% | Unchanged | History |
| STOKStoke Therapeutics, Inc. | COM | 210,000 | $2.58M | 2.2% | 00.0% | Unchanged | History |
| PTGXProtagonist Therapeutics, Inc | COM | 48,000 | $2.16M | 1.9% | 00.0% | Unchanged | History |
| TVTXTravere Therapeutics, Inc. | COM | 148,000 | $2.07M | 1.8% | +26,000+21.3% | Added | History |
| MASIMasimo Corp | COM | 15,280 | $2.04M | 1.8% | 00.0% | Unchanged | History |
| OVVOvintiv Inc. | COM | 52,200 | $2.00M | 1.7% | −22,000−29.6% | Reduced | History |
| DCGODocGo Inc. | COM | 515,000 | $1.71M | 1.5% | +55,000+12.0% | Added | History |
| CSTLCastle Biosciences Inc | COM | 58,000 | $1.65M | 1.4% | +24,000+70.6% | Added | History |
| ALKSAlkermes plc. | SHS | 50,000 | $1.40M | 1.2% | 00.0% | Unchanged | History |
| EQTEQT Corp | Stock | 34,619 | $1.27M | 1.1% | +34,619 | New | History |
| ATECAlphatec Holdings, Inc. | COM NEW | 198,000 | $1.10M | 1.0% | +110,000+125.0% | Added | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 82,000 | $949.6K | 0.8% | +36,000+78.3% | Added | History |
| KNSAKiniksa Pharmaceuticals International, plc | COM CL A | 30,000 | $749.7K | 0.6% | 00.0% | Unchanged | History |
| TXG10x Genomics, Inc. | CL A COM | 30,000 | $677.4K | 0.6% | 00.0% | Unchanged | History |
| HALOHalozyme Therapeutics, Inc. | COM | 10,000 | $572.4K | 0.5% | 00.0% | Unchanged | History |
| AXDXAccelerate Diagnostics, Inc | COM | 325,239 | $556.2K | 0.5% | 00.0% | Unchanged | History |
| CYTKCytokinetics Inc | COM NEW | 10,000 | $528.0K | 0.5% | 00.0% | Unchanged | History |
| INBXInhibrx Biosciences, Inc. | COM | 32,110 | $502.8K | 0.4% | +20,000+165.2% | Added | History |
| KROSKeros Therapeutics, Inc. | COM | 7,000 | $406.5K | 0.4% | 00.0% | Unchanged | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 14,000 | $403.8K | 0.3% | 00.0% | Unchanged | History |
| TMCITreace Medical Concepts, Inc. | COM | 68,350 | $396.4K | 0.3% | +68,350 | New | History |
| XENEXenon Pharmaceuticals Inc. | COM | 10,000 | $393.7K | 0.3% | 00.0% | Unchanged | History |
| KPTIKaryopharm Therapeutics Inc. | COM | 469,832 | $390.0K | 0.3% | 00.0% | Unchanged | History |
| CHRSCoherus Oncology, Inc. | COM | 372,000 | $386.9K | 0.3% | +102,000+37.8% | Added | History |
| ARVNArvinas, Inc. | COM | 15,000 | $369.4K | 0.3% | 00.0% | Unchanged | History |
| PGNYProgyny, Inc. | COM | 22,000 | $368.7K | 0.3% | 00.0% | Unchanged | History |
| BHVNBiohaven Ltd. | COM | 7,365 | $368.0K | 0.3% | 00.0% | Unchanged | History |
| AXSMAxsome Therapeutics, Inc. | COM | 4,000 | $359.5K | 0.3% | 00.0% | Unchanged | History |
| CGEMCullinan Therapeutics, Inc. | COM | 20,000 | $334.8K | 0.3% | 00.0% | Unchanged | History |
| WVEWave Life Sciences, Inc. | SHS | 40,000 | $328.0K | 0.3% | 00.0% | Unchanged | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 10,000 | $320.4K | 0.3% | 00.0% | Unchanged | History |
| NVCRNovoCure Ltd | ORD SHS | 20,000 | $312.6K | 0.3% | 00.0% | Unchanged | History |
| SRPTSarepta Therapeutics, Inc. | COM | 2,500 | $312.2K | 0.3% | 00.0% | Unchanged | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 40,000 | $304.0K | 0.3% | 00.0% | Unchanged | History |
| FOLDAmicus Therapeutics, Inc. | COM | 28,000 | $299.0K | 0.3% | 00.0% | Unchanged | History |
| BPMCBlueprint Medicines Corp | COM | 2,700 | $249.8K | 0.2% | +2,700 | New | History |
| XNCRXencor Inc | COM | 12,300 | $247.4K | 0.2% | 00.0% | Unchanged | History |
| GOSSGossamer Bio, Inc. | COM | 138,176 | $136.3K | 0.1% | 00.0% | Unchanged | History |
| BLUEbluebird bio, Inc. | COM | 211,200 | $109.7K | 0.1% | −100,000−32.1% | Reduced | History |
| ALMSAlumis Inc. | COM | 10,000 | $106.8K | 0.1% | +10,000 | New | History |
| LQDALiquidia Corp | COM NEW | 10,000 | $100.0K | 0.1% | 00.0% | Unchanged | History |
| QUREuniQure N.V. | SHS | 20,000 | $98.6K | 0.1% | +20,000 | New | History |
| IFRXInflaRx N.V. | COM | 50,000 | $76.5K | 0.1% | 00.0% | Unchanged | History |
| TSVT2seventy bio, Inc. | COMMON STOCK | 15,833 | $74.7K | 0.1% | −2,000−11.2% | Reduced | History |
| VTYXVentyx Biosciences, Inc. | COM | 28,800 | $62.8K | 0.1% | 00.0% | Unchanged | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 16,000 | $58.9K | 0.1% | 00.0% | Unchanged | History |
| CABACabaletta Bio, Inc. | COM | 10,000 | $47.2K | <0.1% | 00.0% | Unchanged | History |
| OMOutset Medical, Inc. | COM | 10,000 | $6.77K | <0.1% | 00.0% | Unchanged | History |
| CEROCero Therapeutics Holdings, Inc. | CLASS A COM | 12,972 | $1.21K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q2 2024 (4)
Positions held at the end of Q2 2024 that are gone from this filing.
| Security | Class | Shares in Q2 2024 | Value in Q2 2024 | % of portfolio in Q2 2024 | History |
|---|---|---|---|---|---|
| SILKSilk Road Medical Inc | COM | 158,094 | $4.27M | 4.0% | History |
| ETRNMidstream Co LLC | COM | 133,050 | $1.73M | 1.6% | History |
| XOMExxonMobil Holdings Corp | COM | 5,849 | $673.3K | 0.6% | History |
| GTHXG1 Therapeutics, Inc. | COM | 80,000 | $182.4K | 0.2% | History |